These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23892209)

  • 41. Androgens and cognitive function.
    Cherrier MM
    J Endocrinol Invest; 2005; 28(3 Suppl):65-75. PubMed ID: 16044582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of testosterone in men's health.
    Ide H
    Endocr J; 2023 Jul; 70(7):655-662. PubMed ID: 37045775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of androgen in the elderly. Frailty and androgen].
    Ogawa S
    Clin Calcium; 2013 Aug; 23(8):1117-22. PubMed ID: 23892211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Investigation, treatment and monitoring of late-onset hypogonadism in males: the official guidelines of the International Society for the Study of the Study of the Aging Male (ISSAM) with comments].
    Cuzin B; Giuliano F; Jamin Ch; Legros JJ; Lejeune H; Rigot JM; Roger M;
    Ann Endocrinol (Paris); 2003 Oct; 64(4):289-304. PubMed ID: 14595242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy.
    La Vignera S; Condorelli R; Vicari E; D'Agata R; Calogero A
    Aging Male; 2011 Sep; 14(3):183-9. PubMed ID: 21271942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
    Lackner JE; Märk I; Schatzl G; Marberger M; Kratzik C
    Urology; 2007 Apr; 69(4):754-8. PubMed ID: 17445664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Androgen-dependent miR-125a-5p targets LYPLA1 and regulates global protein palmitoylation level in late-onset hypogonadism males.
    Qu M; Zhao Y; Qing X; Zhang X; Li H
    J Cell Physiol; 2021 Jun; 236(6):4738-4749. PubMed ID: 33284463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testosterone and men's quality of life.
    Moncada I
    Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
    Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
    Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testosterone supplementation: why and for whom?
    Gooren L
    Aging Male; 2003 Sep; 6(3):184-99. PubMed ID: 14628499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of life in elderly men with androgen deficiency.
    Finas D; Bals-Pratsch M; Sandmann J; Eichenauer R; Jocham D; Diedrich K; Schmucker P; Hüppe M
    Andrologia; 2006 Apr; 38(2):48-53. PubMed ID: 16529575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-related androgen deficiency and type 2 diabetes.
    Ryan GJ; Jobe LJ
    J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers.
    Tancredi A; Reginster JY; Schleich F; Pire G; Maassen P; Luyckx F; Legros JJ
    Eur J Endocrinol; 2004 Sep; 151(3):355-60. PubMed ID: 15362965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sports or hormones for aging men? When Adam suffers from PADAM (partial androgen deficit of the aging man)].
    Schicker I
    MMW Fortschr Med; 2000 Aug; 142(35):12-3. PubMed ID: 11006697
    [No Abstract]   [Full Text] [Related]  

  • 57. Counterpoint: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
    Casey RW
    Can J Urol; 2002 Dec; 9(6):1681-3. PubMed ID: 12517309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.
    Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M
    Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reproductive aging in men.
    Basaria S
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):255-70. PubMed ID: 23702400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.